Biolife stock.

Biolife Solutions stocks price quote with latest real-time prices, charts, financials, latest news, ... Do the numbers hold clues to what lies ahead for the stock? BLFS: 20.37 ( …BioLife Sciences is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and ...BLFE | Complete BioLife Sciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.WebBioLife Solutions (NASDAQ:BLFS) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the superior stock?We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership, media sentiment and community ranking.BioLife Solutions has signed a 10-year deal to supply Kite with its CryoStor media for freezing samples, which Kite will use to transport materials for its next-generation cancer treatments.

Dec 4, 2023 · Biolife Solutions Inc (NASDAQ:BLFS) has a beta value of 1.60 and has seen 2.24 million shares traded in the last trading session. The company, currently valued at $596.91M, closed the last trade at $13.25 per share which meant it gained $0.88 on the day or 7.11% during that session. The BLFS stock ...

Nov 8, 2023 · Biolife Solutions releases figures for Q3 on November 9. Wall Street analysts predict losses per share of $0.364. Go here to track Biolife Solutions stock price in real-time ahead of earnings. BioLife Sciences Inc. is a commercialization accelerator, licensor and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The Company's core business develops, licenses and distributes antimicrobial products and disruptive technology.

Historical daily share price chart and data for BioLife Solutions since 1992 adjusted for splits and dividends. The latest closing stock price for BioLife Solutions as of December 01, 2023 is 13.25.. The all-time high BioLife Solutions stock closing price was 140.00 on December 15, 1992.; The BioLife Solutions 52-week high stock price is 26.89, which is 102.9% …WebFiscal Q3 2023 ended 9/30/23. Reported on 11/9/23. Get the latest BioLife Solutions Inc (BLFS) real-time quote, historical performance, charts, and other financial information to help you make ... BioLife Solutions, Inc. is a life sciences company. The Company develops, manufactures, and markets bioproduction tools and services which are designed to de-risk biologic manufacturing, storage, distribution, and transportation in the cell and gene therapy (CGT) industry and broader biopharma markets.BioLife Solutions, Inc. (“BioLife”, “us”, “we”, “our”, or the “Company”) is a developer, manufacturer, and supplier of a portfolio of bioproduction tools and services including proprietary biopreservation media, automated cell processing fill machines, closed system cryogenic vials, human platelet lysate (“hPL”) growth ...

When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll want to ensure that you find the best one available in stock.

BLFE: Biolife Sciences Inc - Stock Price, Quote and News - CNBCWeb

BOTHELL - BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ('CGT') and broader biopharma markets, today announced the launch of Ultraguard, the first ever non-toxic, non-hazardous and non-flammable -70-degreeC phase change material ('PCM'), for ultra-low temperature (ULT) protection.What really drove the stock down was BioLife's guidance. Management now expects yearly revenue to be between $144 million and $158 million, meaning a drop of between 2% and 11% over 2022.Beta 0.53. Rev. per Employee $608.79K. P/E Ratio 31.69. EPS $0.44. Yield 3.96%. Dividend $0.31. Ex-Dividend Date Mar 30, 2023. Short Interest 8.71M 10/31/23. % of Float Shorted 0.28%.Complete BioLife Solutions Inc. stock information by Barron's. View real-time BLFS stock price and news, along with industry-best analysis. BioLife Solutions is trading near 52-week lows as its growth story has floundered and profitability remains uncertain. Learn why I rate BLFS stock a hold.

Nasdaq -23.34(-0.16%) Russell 2000 +10.01 BioLife Solutions, Inc. (BLFS) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 14.14 +0.57 (+4.20%) …Mar 27, 2023 · BANNOCKBURN, Ill., March 27, 2023--BioLife Plasma Services, part of the global biopharmaceutical company Takeda, today announced the opening of its 200th plasma donation center in the United ... BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy (CGT) and broader biopharma markets, today announced ...BIOLIFE SOLUTIONS INC NEW COM STK (DE); BioLife Solutions, Inc. BioLife Solutions, Inc. View SEC Filings ... Stock Lookup. Enter stock name: use * for wildcard.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Biolife Solutions share forecasts, stock quote and buy / sell signals below. According to present data Biolife Solutions's BLFS shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Biolife Sciences Inc (BLFE) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2023 Earnings Call Transcript November 9, 2023 BioLife Solutions, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.38. Operator: Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to the BioLife Solutions Third Quarter 2023 Shareholder and Analyst ...

BioLife Sciences is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and ...

Roderick de Greef appointed Chairman and Chief Executive Officer bringing 20+ years of prior BioLife experience. Garrie Richardson appointed Chief Revenue Officer. Preliminary Q3 revenue of $33.3 million and expect 2023 revenue at the low end of the previously announced guidance range . BOTHELL, Wash., Oct. 19, 2023 /PRNewswire/ - …WebBiolife Solutions story: Exercise or conversion by Karen Foster of 16332 shares of Biolife Solutions subject to Rule 16b-3 and other headlines for Biolife Solutions Please click here if you are not redirected within a few seconds.The stock seems fairly valued at the moment according to my valuation model. It’s trading around 20% below my intrinsic value, which means if you buy BioLife Solutions today, you’d be paying a ...Dec 1, 2023 · BioLife Solutions, Inc. is a life sciences company. The Company develops, manufactures, and markets bioproduction tools and services which are designed to de-risk biologic manufacturing, storage, distribution, and transportation in the cell and gene therapy (CGT) industry and broader biopharma markets. Mar 2, 2023 · BOTHELL - BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ('CGT') and broader biopharma markets, today announced the launch of Ultraguard, the first ever non-toxic, non-hazardous and non-flammable -70-degreeC phase change material ('PCM'), for ultra-low temperature (ULT) protection. Biolife Stock Ipo: Can You Buy Stock In This Plasma Company? It’s a captivating David vs. Goliath story, where David — at least on some fronts — appears to be winning. When a stock goes ex-dividend, the value of that stock effectively falls by the dividend amount. This means if you hold a spread bet or CFD position on a company …

According to 5 analysts, the average rating for BLFS stock is "Strong Buy." The 12-month stock price forecast is $26.0, which is an increase of 137.44% from the latest price.

BioLife Plasma, L.L.C. 1200 Lakeside Drive Bannockburn, IL 60015, USA . BioLife Plasma Services L.P. 1200 Lakeside Drive Bannockburn, IL 60015, USA . Baxalta US Inc. 1200 Lakeside Drive Bannockburn, IL 60015, USA NOTE: This entity uses a business operating address of 300 Shire Way, Lexington, MA 02421, USA ONLY FOR Regulatory/FDA …

BioLife Sciences is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and ...15 Sep, 2021, 08:00 ET. BOTHELL, Wash., Sept. 15, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS ) ("BioLife" or the "Company"), a leading developer and supplier of class-defining ...Biolife Sciences Inc (BLFE) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Octapharma to present new clinical and scientific data at ASH 2023 from ongoing research initiatives aimed at advancing care for people living with bleeding disordersGet the latest Takeda Pharmaceutical Co Ltd (TAK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Nov 29, 2023 · BioLife was founded as Trans Time Medical Products in 1987 and went public in 1989, raising net proceeds of $4.6 million at $105 per share (after giving effect to 1-for-five (2000) and 1-for-14 ... BioLife will issue 6,646,870 shares of common stock for 100% of the outstanding shares of Stirling in an all-stock transaction, which is expected to close early in the second quarter of 2021. With Stirling, BioLife believes that total GAAP revenue in 2021 will exceed $100 million and the transaction is expected to be accretive on an adjusted ...Chief Quality Officer Of Biolife Solutions Trades $760K In Company Stock. (Benzinga) Sep-20-21 08:00AM. BioLife Solutions Appoints Joydeep Goswami, MBA, PhD to Board of Directors. (PR Newswire) BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings ...BioLife Solutions was up solidly in Monday’s trading session on positive results from a Phase 3 study. ... Stock Market News. Economic News. Morning Brief. Personal Finance. Crypto News.The estimated net worth of Troy Wichterman is at least $861,719.60 as of November 13th, 2023. Mr. Wichterman owns 67,480 shares of BioLife Solutions stock worth more than $861,720 as of November 18th. This net worth estimate does not reflect any other investments that Mr. Wichterman may own.Jun 26, 2020 · BLFS. BioLife Solutions, Inc. 11.83. +1.05. +9.74%. The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of ... Dec 4, 2023 · BioLife Solutions Stock Up 7.1 %. Shares of NASDAQ BLFS opened at $13.25 on Monday. BioLife Solutions, Inc. has a one year low of $8.92 and a one year high of $26.89. The company has a debt-to ...

Stock Information; Investor Contact; Investor Contact. Media & Investor Relations: Troy Wichterman Chief Financial Officer (425) 402 - 1400 ... BioLife Solutions Inc. 3303 Monte Villa Parkway, Suite 310, Bothell, WA 98021 USA. T +1.866.424.6543 or 425.402.1400 F +1.425.402.1433 E [email protected]. NAVIGATION.WebDec 1, 2023 · Dividends. A high-level overview of BioLife Solutions, Inc. (BLFS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Biolife Keto Gummies helps in boosting your immunity and digestion power and makes you becomes healthy and fit in short period of time. Thursday, Nov 30, 2023 LoginWebStock gifts should include both the number of stocks given and the stock name. It should not include the fair market value of the stock. Donations of cryptocurrency should include the amount donated and the type of currency. For gifts of property, the physical address/location should be marked on the letter so the IRS can match it with any ...Instagram:https://instagram. what is the best forex trading brokerhow much is a hospital visitfngg holdingsbest mba book Nov 30, 2023 · BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company’s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. BioLife Solutions Biopreservation Media Products Outperform Traditional, Non-Optimized Formulations BOTHELL, WA-January 27, 2012- BioLife Solutions Inc.( OTC BB: BLFS), a leading developer, manufacturer, and marketer of proprietary hypothermic storage and cryopreservation freeze media for cells and tissues, today announced that … top dividend reit stocksperrigo shares BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2023 Earnings Call Transcript November 9, 2023 BioLife Solutions, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.38 ... neurlink stock BioLife stock price (as of May 3, 2021) $ 35.07 : Value of issued shares $ 232,741 : plus: Settlement of BioLife prepaid deposits $ 2,152 : plus: Net settlement of BioLife accounts receivable $ 16 : Merger Consideration $ 234,909 .WebBioLife Solutions NasdaqCM:BLFS Stock Report Last Price US$12.37 Market Cap US$563.5m 7D -8.8% 1Y -43.4% Updated 30 Nov, 2023 Data Company …Get the latest BioLife Solutions, Inc. (BLFS) stock quote, history, news and other vital information to help you with your stock trading and investing. See the company's …